CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The CCAAT/enhancer binding protein epsilon (C/EBPepsilon) is a nuclear transcription factor expressed predominantly in myeloid cells and implicated as a potential regulator of myeloid differentiation. We show that it was rapidly induced in the acute promyelocytic leukemia (APL) cell line NB4 during granulocytic differentiation after exposure to retinoic acid (RA). Our data suggest that induction of C/EBPepsilon expression was through the retinoic acid receptor alpha (RARalpha) pathway. Reporter gene studies showed that C/EBPepsilon promoter/enhancer activity increased in a retinoid-dependent fashion via the retinoic acid response element (RARE) present in the promoter region of C/EBPepsilon. The RA-induced expression of C/EBPepsilon markedly increased in U937 myelomonoblasts that were induced to express promyelocytic leukemia/RARalpha (PML/RARalpha), but not in those induced to express promyelocytic leukemia zinc finger/RARalpha (PLZF/RARalpha). In retinoid-resistant APL cell lines, C/EBPepsilon either is not induced or is induced only at very high concentrations of RA (>/=10(-6) M). In addition, forced expression of C/EBPepsilon in the U937 myelomonoblastic leukemia cells mimicked terminal granulocytic differentiation, including morphologic changes, increased CD11b/CD66b expression, and induction of secondary granule protein expression. Our data strongly suggest that C/EBPepsilon is a downstream target gene responsible for RA-induced granulocytic differentiation of APL cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Differentiation induction of haematological malignant cells as well as normal HSC differentiation is mediated by a stochiometric ratio of transcription factors GATA-1 and PU.1 [41], which broadly determine lineage and cooperate with more specific transcription factors such as RAR receptor and CEBP family members [59, 93, 94].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439 · cited 1×
“Retinoids and their nuclear receptors appear to have multiple functions in the regulation of normal cellular differentiation (1).”
BackgroundUse of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445 · cited 1×
“Recently, all-trans retinoic acid (ATRA) has become a standard therapy for the induction of remissions in patients with acute promyelocytic leukemia (APL) (4, 5).”
Background9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., & Thaller, C. (1992) · Cell · doi:10.1016/0092-8674(92)90479-v · Cited by 1,780 · cited 1×
“ATRA binds RAR but does not bind RXR; 9-cis retinoic acid (RA), a naturally occurring RA double-bond isomer, on the other hand, can bind to both RAR/RXR and RXR/RXR receptors (6, 7).”
BackgroundUmesono, K., Murakami, K. K., Thompson, C. C., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90020-y · Cited by 1,716 · cited 2×
“The ligand-receptor complexes transactivate downstream genes that have RAR recognition sequences (8, 9).”
BackgroundMethodLuckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701 · cited 6×
“A CAT reporter construct that does not contain a putative RARE site (PRE) was used as a negative control.”
MethodInfluentialKliewer, S. A., Umesono, K., Mangelsdorf, D. J., & Evans, R. M. (1992) · Nature · doi:10.1038/355446a0 · Cited by 1,489 · cited 1×
“The retinoic acid receptor (RAR) forms a heterodimeric complex with the retinoid X receptor (RXR) and has an important function in the transactivation of myeloid-specific genes (2, 3).”
BackgroundKakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
Self-citationde Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355 · cited 2×
“The ligand-receptor complexes transactivate downstream genes that have RAR recognition sequences (8, 9).”
BackgroundDifferentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251 · cited 1×
“Recently, all-trans retinoic acid (ATRA) has become a standard therapy for the induction of remissions in patients with acute promyelocytic leukemia (APL) (4, 5).”
BackgroundSelf-citation9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα
Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., ratzeisen, C., Rosenberger, M., Lovey, A., et al. (1992) · Nature · doi:10.1038/355359a0 · Cited by 1,222 · cited 1×
“ATRA binds RAR but does not bind RXR; 9-cis retinoic acid (RA), a naturally occurring RA double-bond isomer, on the other hand, can bind to both RAR/RXR and RXR/RXR receptors (6, 7).”
Background
Cited by
Items 101–188 of 188
Potential role of retinoids in ovarian physiology and pathogenesis of polycystic ovary syndrome
Jiang, Y., Li, C., Chen, L., Wang, F., & Zhou, X. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.03.025 · Cited by 31
Differentiation induction as a treatment for hematologic malignancies
Miller, W. H., & Waxman, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205328 · Cited by 31
“…by a stochiometric ratio of transcription factors such as GATA-1 and PU-1 (Rekhtman et al., 1999) which broadly determine lineage and cooperate with more speci®c transcription factors such as RAR receptor and CEBP family members (Matushansky et al., 2000; Park et al., 1999; Tenen et al., 1997).”
BackgroundSelf-citationLou, S., Gao, H., Hong, H., Zhu, Z., & Zhao, H. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01941-7 · Cited by 27
“Interestingly, the overexpression of RARαS77A alone could activate transcription of direct RA-target genes such as p21 [30], Caspase-9 [31], C/EBPε [32], RARβ2 [33], and CYP26A1 [34] (Fig.”
BackgroundWitcher, M., Shiu, H. Y., Guo, Q., & Miller, W. H. (2004) · Blood · doi:10.1182/blood-2004-01-0023 · Cited by 29
Self-citationMaun, N. A., Gaines, P. C. W., Khanna‐Gupta, A., Zibello, T., Enriquez, L., Goldberg, L., & Berliner, N. (2003) · Blood · doi:10.1182/blood-2002-10-3247 · Cited by 27
Representational difference analysis using myeloid cells from C/EBPε deletional mice
Kubota, T., Kawano, S., Chih, D. Y., Hisatake, Y., Chumakov, A. M., Taguchi, H., & Koeffler, H. P. (2000) · Blood · doi:10.1182/blood.v96.12.3953 · Cited by 26
Self-citationMao, W., Liu, Z., Chen, R., Li, A., & Zhou, J. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04446.x · Cited by 25
Lee, Y.-J., Jones, L. C., Timchenko, N. A., Perrotti, D., Tenen, D. G., & Kogan, S. C. (2006) · Blood · doi:10.1182/blood-2006-02-003582 · Cited by 26
“Prior studies16,17 provide evidence that C/EBP and C/EBP may play a role in the pathogenesis of acute promyelocytic leukemia (APL), a subtype of AML in which a t(15;17) chromosomal translocation juxtaposes the promyelocytic (PML) gene to the retinoic acid receptor (RARA) gene, creating an aberrant PML-RAR fusion prote…”
BackgroundIriyama, N., Yuan, B., YOSHINO, Y., Hatta, Y., Horikoshi, A., Aizawa, S., Takei, M., Takeuchi, J., Takagi, N., & Toyoda, H. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2236 · Cited by 22
“Although a number of studies have been conducted to explore the molecular mechanism underlying the effects of ATRA on these transcription factors associated with differentiation induction (16,18,19,22), the effects of VPA alone or in combination with ATRA on human APL cell line harboring PML-RARα remain largely unclea…”
BackgroundInfluentialLennartsson, A., Garwicz, D., Lindmark, A., & Gullberg, U. (2005) · Gene · doi:10.1016/j.gene.2005.05.004 · Cited by 22
Weng, X., Sheng, Y., Ge, D.-Z., Wu, J., Shi, L., & Cai, X. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.03.008 · Cited by 22
Chen, F., Zhou, K., Zhang, L., Ma, F., Chen, D., Cui, J., Feng, X., Yang, S., Chi, Y., Han, Z., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0621 · Cited by 20
“Our findings show that mechanism underlying UC-MSC-induced differentiation overlaps with that of ATRA in G0/G1 cell cycle arrest [39], downregulation of c-Myc [64], upregulation of C/EBP b [43] and C/EBP e [44], and activation of the MEK/ERK-signaling pathway [57] in NB4 cells.”
Higuchi, T., Kizaki, M., & Omine, M. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.09.014 · Cited by 20
“The expression of C/EBPε is up-regulated by retinoids and the differentiation of APL cells by retinoids is linked to the retinoid-dependent induction of C/EBPε [11,33–37].”
BackgroundBao, F., Polk, P., Nordberg, M. L., Veillon, D. M., Sun, A., Deininger, M. W., Murray, D. L., Andersson, B. S., & Munker, R. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.03.002 · Cited by 18
Han, M., Baek, S., Kim, S., Kang, C., & Oh, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126085 · Cited by 20
“Furthermore, all-trans retinoic acid (ATRA) can induce differentiation of CSCs in acute promyelocytic leukemia (APL) via C/EBP factors [16,17], wild type transcription factors, such as, C/EBPα, can induced differentiation in human AML and in lung cancer cell lines and in mouse in vivomodels [17,18,19,20].”
BackgroundVitamin A and its Derivatives- Retinoic Acid and Retinoid Pharmacology
Zhu, G. (2019) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2019.03.000656 · Cited by 21
“In contrast to its repression, in the presence of a pharmacologic concentration of RA, pml/RARa significantly increased the level of C/EBPepsilon expression in a time and dose-dependent manner [161].”
BackgroundInfluentialCassinat, B., & Chomienne, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204761 · Cited by 19
“…et al., 1999), a concomitant increase of the C/EBPe gene, which regulates most genes of the speci®c granule proteins (Morosetti et al., 1997; Park et al., 1999) and a subsequent expression of genes coding for molecules linked with cell adhesion, such as speci®c integrins (CD11b, CD18),…”
BackgroundMann, K. K., Rephaeli, A., Colosimo, A. L., Diaz, Z., Nudelman, A., Levovich, I., Jing, Y., Waxman, S., & Miller, W. H. (2003) · PubMed · Cited by 20
Self-citationLou, S., Liu, G., Shimada, H., Yang, X., He, Q., & Wu, L. (2013) · Stem Cells · doi:10.1002/stem.1444 · Cited by 16
Molecular Mechanisms of the Antileukemia Activities of Retinoid and Arsenic
Nitto, T., & Sawaki, K. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14r15cp · Cited by 16
Lennartsson, A., Vidovic, K., Bjerregaard, M. D., Cowland, J. B., & Gullberg, U. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205759 · Cited by 15
“Treatment of the cells with all-trans retinoic acid (ATRA) results in induction of neutrophil maturation, including upregulation of C/EBP and C/EBPe [ 32 , 33].”
BackgroundResultInfluentialLi, L., Qi, X., Sun, W., Abdel‐Azim, H., Lou, S., Zhu, H., Prasadarao, N. V., Zhou, A. Y., Shimada, H., Shudo, K., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606434 · Cited by 16
“…throughout the full differentiation induction period (Fig 2Bi, days 2, 3, 6), including tumor suppressor RARb2 (Soprano et al, 2004; Alvarez et al, 2007), terminal granulocytic differentiation regulator C/EBPe (Park et al, 1999; Lekstrom-Himes, 2001), and CR3 component CD11b (Park et al, 1999).”
InfluentialWang, Y., Fu, L., Sun, A., Tang, D., Xu, Y., Li, Y., Chen, M., & Zhang, G. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.137 · Cited by 16
Chen, S., Yan, X., Zhou, G., & Chen, Z. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm011 · Cited by 15
Abdel‐Azim, H., Sun, W., & Wu, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107403 · Cited by 16
Ding, M., Weng, X., Sheng, Y., Wu, J., Cui, L., & Cai, X. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.10.053 · Cited by 15
The Design of Selective and Non-selective Combination Therapy for Acute Promyelocytic Leukemia
Jing, Y., & Waxman, S. (2007) · Springer eBooks · doi:10.1007/978-3-540-34594-7_13 · Cited by 15
Derangement of transcription factor profiles during in vitro differentiation of HL60 and NB4 cells
Bjerregaard, M. D., Borregaard, N., & Cowland, J. B. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.07.019 · Cited by 16
Kang, C., Kim, C., Kim, H. S., Park, S., & Chung, H. (2018) · International Journal of Stem Cells · doi:10.15283/ijsc18021 · Cited by 13
“a terminal differentiation marker of granulocytes (25).”
Cui, L., Ding, M., Weng, X., Sheng, Y., Wu, J., Li, Z.-Y., & Cai, X. (2019) · PubMed Central · Cited by 13
Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells
Liddo, R. D., Bridi, D., Gottardi, M., ANGELI, S. D., Grandi, C., Tasso, A., Bertalot, T., Martinelli, G., Gherlinzoni, F., & Conconi, M. T. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3370 · Cited by 15
“In samples treated for 72 h with ADM22-52, FCM analysis evidenced a significant increase in the expression level of CD11b, a subunit of αMβ2 integrin, CD11c, an integrin αX, and CD66b, a granulocyte-specific activation antigen expressed on secondary granule membranes, that are all associated with granulocytic differen…”
MethodSignaling revisited in acute promyelocytic leukemia
Lutz, P. G., Moog‐Lutz, C., & Cayre, Y. (2002) · Leukemia · doi:10.1038/sj.leu.2402728 · Cited by 12
Balmer, J. E., & Blomhoff, R. (2009) · Journal of Molecular Evolution · doi:10.1007/s00239-009-9238-1 · Cited by 14
“Park et al. (1999) studied this noncoding region and identified a putative site, S = aggtca ggagg aggtag, by sequence analysis.”
BackgroundKim, D.-Y., Choi, S., Kim, S.-H., Chung, H. Y., Yi, S., Kim, D., Kim, C.-C., & Han, T.-H. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500102589 · Cited by 11
“The RA target genes in APL cells, however, are not well known and only a few candidate genes have been identified [7,8].”
BackgroundXi, H.-M., Lu, H., Weng, X., Sheng, Y., Wu, J. Y., Li, L., & Cai, X. (2023) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520623666230110121629 · Cited by 10
Expression of Bactericidal/Permeability-Increasing Protein Requires C/EBPϵ
Tanaka, M., Gombart, A. F., Koeffler, H., & Shiohara, M. (2007) · International Journal of Hematology · doi:10.1532/ijh97.05162 · Cited by 10
“U937pMTe32 cells grown in the presence of ZnSO4 started to show morphologic features of differentiation at 4 to 5 days after ZnSO4 addition [ 28 ]; however, at 48 hours they showed a blastic morphology indistinguishable from those of U937pMT and wild-type cells (data not shown).”
ResultSelf-citationAcute Promyelocytic Leukemia: A View from a Mouse
Kogan, S. C. (2000) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0345 · Cited by 9
Wang, X., Chen, J., Lv, Z., Nie, Z., Wang, D., Shen, H., Wang, X., Wu, X., & Zhang, Y. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21333 · Cited by 10
Hennig, D., Müller, S., Wichmann, C. W., Drube, S., Pietschmann, K., Pelzl, L., Grez, M., Bug, G., Heinzel, T., & Krämer, O. H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.589 · Cited by 10
“These data additionally verify that C/EBPe is an RAR-induced gene (Chih et al, 1997; Morosetti et al, 1997; Park et al, 1999; Duprez et al, 2003) and that PMLRARa can suppress the expression of C/EBPe (Hu and Saunthararajah, 2012).”
BackgroundInfluentialRetinoic acid receptor fusion proteins: friend or foe
Ridder, M. B.-D., Löwenberg, B., & Jansen, J. H. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00255-0 · Cited by 8
Single-cell multiomics reveals a gene regulatory circuit driving leukemia cell differentiation
Tian, X., Zhang, L., Tang, Y., Xiang, G., Wang, Z., Zhu, P., Yu, S., Jiang, F., Wang, S., Wang, J., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03309-z · Cited by 7
“Detailed cell culture protocols were shown in Supplementary Information.”
Verdi, J., Sharif, S., Banafshe, H. R., & Shoae‐Hassani, A. (2014) · Cell Biology International · doi:10.1002/cbin.10283 · Cited by 8
“Transcriptional activation by RA receptors may induce differentiation (Park et al., 1999), cell cycle arrest (Laudet and Gronemeyer, 2002; Donato et al., 2007), and apoptosis (Altucci et al., 2001; Kitareewan et al., 2002), and thus leads to inhibition of cell proliferation.”
BackgroundChen, Z., & Wang, Z. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-307-1_21 · Cited by 8
Song, P., Zhao, J., Zhang, W., Ji, B., Ji, B., & Zhao, J. (2024) · BMC Genomics · doi:10.1186/s12864-024-10161-0 · Cited by 7
“Currently, there is increasing evidence that RA inhibits cell proliferation and promotes cell differentiation in different tissues or cells [27, 42–44].”
BackgroundRetinoids and steroids in bovine mammary gland immunobiology
Meyer, E., Lamote, I., & Burvenich, C. (2005) · Livestock Production Science · doi:10.1016/j.livprodsci.2005.10.011 · Cited by 7
“Examples are C/EBPE, a transcription factor which is a member of the family of CCAAT/enhancer binding proteins (Park et al., 1999) and CaM kinase kinase a, a member of the Ca/calmodulin-dependent kinase cascade (Lawson et al.”
BackgroundCui, L., Ding, M., Weng, X., Sheng, Y., Wu, J., & Cai, X. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.02.033 · Cited by 6
Enikeev, A. D., Komelkov, A. V., Akselrod, M. E., & Tchevkina, E. M. (2019) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2019-18-4-43-50 · Cited by 6
Zhang, F., Zhu, Y., Deng, W. L., Zhu, J., & Zhang, J. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0316-116r · Cited by 5
“It was demonstrated recently that PML/RARa represses the expression of both C/EBPe itself and C/EBPe targets in pathologic conditions [11, 32] but enhances C/EBPe levels markedly in the presence of ATRA [33].”
BackgroundVITAMIN A, RETINOIC ACID AND TAMIBAROTENE, A FRONT TOWARD ITS ADVANCES: A REVIEW
Zhu, G., & Al-Kaf, A. G. (2019) · Universal Journal of Pharmaceutical Research · doi:10.22270/ujpr.v3i6.215 · Cited by 7
Enzastaurin enhances ATRA-induced differentiation of acute myeloid leukemia cells.
Li, Z.-Y., Cui, L., Ding, M., Weng, X., Sheng, Y., Wu, J., Lü, H., & Cai, X. (2020) · American Journal of Translational Research · Cited by 6
Wiernik, P. H., Gallagher, R. E., & Tallman, M. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_23 · Cited by 6
Takitani, K., Koh, M., Zhu, C., Inoue, A., Kuno, T., Tanoue, H., Miyake, M., Nakagawa, T., & Tamai, H. (2003) · Leukemia · doi:10.1038/sj.leu.2402818 · Cited by 4
Chen, C., Wen, Y.-F., Huang, P.-T., Hsu, M.-H., Lee, K., Chen, M.-H., Shin, W.-C., Huang, L.-J., & Kuo, S. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.02.023 · Cited by 5
DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein ε (C/EBPε) gene
Kubota, T., Hirama, T., Verbeek, W., Kawano, S., Chih, D. Y., Chumakov, A. M., Taguchi, H., & Koeffler, H. P. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00065-0 · Cited by 4
Self-citationTallman, M. S. (2014) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2014.04.010 · Cited by 5
Molecular genetics of acute myeloid leukemia
Gruber, T. A., & Downing, J. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.009 · Cited by 3
Cai, R., Cai, X., Chen, B., Xu, W., & Lu, J. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0034-1 · Cited by 2
“Previous studies revealed that C/EBPe expression is markedly upregulated when NB4 and U937 promyelocytes are induced by retinoids to differentiate into granulocytes [5, 6].”
BackgroundLentiviral-Mediated shRNA Approaches: Applications in Cellular Differentiation and Autophagy
Orfali, N. M., Jeyapalan, J. N., Woodcock, C. L., O’Donovan, T. R., Benjamin, D., Cahill, M. R., McKenna, S. L., Gudas, L. J., & Mongan, N. P. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9585-1_3 · Cited by 2
Lázničková, P., Tidu, F., Hrdý, J., Boráková, K., Kohoutková, M. H., & Frič, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-19454-0 · Cited by 1
“These genes have known roles in RA signaling, with CEBPA also containing a RARE in its promoter 40 and SPI1 regulated by CEBPA 41 .”
Understanding the Role of All-Trans Retinoic Acid in Acute Myeloid Leukemia Cells
Sadoun, H. A., Alamoudi, F., Alamoudi, N., Tayeb, H. H., Felimban, R. I., Alserihi, R. F., Yasin, E. B., Khan, R. H., & Noorwali, A. A. (2025) · World Journal of Oncology · doi:10.14740/wjon2676 · Cited by 1
“In particular, CEBP α has been described as a key target in ATRA-induced differentiation [22].”
Acute Promyelocytic Leukemia: A Model Disease for Targeted Cancer Therapy
Lång, E., & Ove, S. (2011) · InTech eBooks · doi:10.5772/26522 · Cited by 1
“C/EBPbeta: a major PML-RARAresponsive gene in retinoic acid-induced differentiation of APL cells.”
BackgroundInfluentialTarget acquisition and acute promyelocytic leukemia
Egan, D. A., & Evans, R. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7118 · Cited by 1
“propose that the gene for the myeloid-specific transcription factor C/EBPε may be such a target (4).”
BackgroundNLS-RARα blocks cell differentiation by inhibiting the retinoic acid signalling pathway
Li, J., Zhong, L., Ye, J., Xiong, L., Yu, L., Dan, W., Zhong, P., Yuan, Z., Liu, D., Yao, J., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.076 · Cited by 1
Chromatin Remodeling During Leukemia Cell Proliferation and Differentiation
Navakauskienė, R., Navakauskas, D., Borutinskaite, V. V., & Matuzevičius, D. (2021) · Springer eBooks · doi:10.1007/978-3-030-68708-3_3 · Cited by 1
Wiernik, P. H., Gallagher, R. E., & Tallman, M. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_21 · Cited by 1
Differentiation therapy for myelodysplastic syndrome.
Hofmann, W., & Koeffler, H. P. (2002) · PubMed · Cited by 1
Self-citationLessard, J. A., & Hoang, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.01004-3 · Cited by 1
Cellular Retinoic Acid Binding Protein and Breast Cancer
Willmert, L. J. (2004) · Defense Technical Information Center (DTIC) · doi:10.21236/ada425991
Promyelocytic Leukemia Zinc Finger Gene
Licht, J. D., & Waxman, S. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm0290
DUAL TRANSCRIPTIONAL ACTIVITIES UNDERLIE OPPOSING EFFECTS OF RETINOIC ACID IN MAMMARY CARCINOMA
Thad, S. (2007) · eCommons (Cornell University)
Pieters, K. (2005) · Lund University Publications (Lund University)
Suh, J. H. (2005) · eCommons (Cornell University)
Gingeras, T., Kapranov, P., Weissman, S. M., Newburger, P. E., Zhang, X., Lian, Z., Padden, C., Gerstein, M., Rozowsky, J. S., & Snyder, M. P. (2009)
Li, Y. (2003) · ThinkTech (Texas Tech University)
Pan, Y., Chen, H., Liang, H., Wang, X., & Wang, L. (2014) · PubMed
The molecular basis of acute myeloid leukemia
Rice, K. L., Buzzai, M., Altman, J. K., & Licht, J. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.070
Luk, I. Y. (2017) · Minerva Access (University of Melbourne)
Differentiation induction in acute promyelocytic leukemia
Ridder, M. C. B.-D. (2001)
Chen, S., Yan, X., Zhou, G., & Zhu, C. H. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm011.pub2
Song, X., Zhang, J., Song, Y., Raza, S. H. A., Pant, S. D., Zan, L., Zhang, G., & Wei, D. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01723-w
“Retinoic acid (RA), the active metabolite of vitamin A, signals through ligand-inducible retinoic acid receptors (RARs) (Park et al. 1999).”
Song, P., Zhao, J., Zhang, W., Li, X., Ji, B., & Zhao, J. (2024) · Figshare · doi:10.6084/m9.figshare.25347216
Song, P., Zhao, J., Zhang, W., Li, X., Ji, B., & Zhao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26689046
Lou, S., Gao, H., Hong, H., Zhu, Z., & Zhao, H. (2021) · Figshare · doi:10.6084/m9.figshare.14489875
Song, P., Zhao, J., Zhang, W., Li, X., Ji, B., & Zhao, J. (2024) · Figshare · doi:10.6084/m9.figshare.25346990
Song, P., Zhao, J., Zhang, W., Li, X., Ji, B., & Zhao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26689049
Lessard, J. A., & Hoang, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00521-4
Roncalli, T., Rémy, É., & Paulevé, L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.02.756175
“The interactions present in all 1,000 retained BNs connect the positive Stat1–Stat2 circuit to a granulocytic-differentiation branch involving Rara and Cebpe [73].”
Analysis of the C/EBP family of transcription factors in neuronal repair
Heredia, L. (2009) · Queen Mary Research Online (Queen Mary University of London)
Metadata
- Authors
- Park, D. J., Chumakov, A. M., Vuong, P. T., Chih, D. Y., Gombart, A. F., Miller, W. H., & Koeffler, H. P.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Lady Davis Institute for Medical Research (CA)
- Corresponding author
- Park, Dorothy J.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-05-15
- Volume
- 103
- Issue
- 10
- Pages
- 1399-1408
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408448
- OpenAlex
- W2042117566
- Cited by
- 187
- References
- 55
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 7 · 2018: 1 · 2017: 7 · 2016: 7 · 2015: 3 · 2014: 11 · 2013: 6 · 2012: 6
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cedars-Sinai Medical Center
- National Institutes of Health
- University of California, Los Angeles
- Jonsson Comprehensive Cancer Center
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- acute promyelocytic leukemia, retinoic acid, retinoic acid receptor alpha, retinoic acid response element, granulocytic differentiation, PML-RARα, PLZF-RARα, retinoid resistance, transcriptional regulation, myeloid differentiation, NB4 cells, U937 cells
- MeSH terms
- Retinoic Acid Receptor alpha, Cell Differentiation, DNA-Binding Proteins, Drug Resistance, Enhancer Elements, Genetic, Humans, Nuclear Proteins, Promoter Regions, Genetic, Retinoids, Tretinoin, Tumor Cells, Cultured, Leukemia, Promyelocytic, Acute, Gene Expression, Genes, Reporter, Receptors, Retinoic Acid, U937 Cells, CCAAT-Enhancer-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.